VLADIMIR ZHODZISHSKY: Open Payments
NPI 1689319857 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 1 | $125 |
| ARGENX US, INC. | 3 | $80 |
| Amgen Inc. | 2 | $60 |
| UCB, Inc. | 1 | $52 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Biocodex, Inc. | 1 | $18 |
Products named: XCOPRI, VYVGART HYTRULO, UPLIZNA, Fintepla, ULTOMIRIS, Sunosi, VYEPTI, DIACOMIT.
Industry payments across MD — which companies pay providers there.
